血糖波动对急性冠脉综合征患者近期主要心血管不良事件的预测价值

doi:10.3969/j.issn.1671-2587.2020.02.023

临床输血与检验 ›› 2020, Vol. 22 ›› Issue (2): 206-210.DOI: 10.3969/j.issn.1671-2587.2020.02.023

血糖波动对急性冠脉综合征患者近期主要心血管不良事件的预测价值

饶楚炳

442008 十堰,湖北医药学院附属东风医院急救医学部

收稿日期:2018-05-10 出版日期:2020-04-20 发布日期:2020-04-16
作者简介:饶楚炳（1975-）,男,湖北郧西人,主治医师,主要从事急诊及危重症工作,（Tel）13387146152（E-mail）raochubing1975@163.com。

A Predictive Value of Blood Glycemic Variability on The Recent Major Cardiovascular Adverse Events in Acute Coronary Syndrom Patients

RAO Chu-bing

Department of Emergency Medicine,The Dongfeng Hospital Affiliated to Hubei University of Medicine,442008

Received:2018-05-10 Online:2020-04-20 Published:2020-04-16

摘要/Abstract

摘要： 目的探讨血糖波动对急性冠脉综合征（ACS）患者近期主要心血管不良事件（MACE）的预测价值。方法连续选择2016年7月~2018年3月医院收治的247例ACS患者作为研究对象,按照30 d内是否发生MACE分为MACE组（n=28）和非MACE组（n=219）,比较两组患者入院时一般资料、生化、超声和血糖波动指标的差异,采用Logistic回归分析ACS患者30 d内发生MACE的独立危险因素,ROC曲线分析血糖波动预测MACE的价值,Kaplan-Meier曲线分析患者30 d内发生MACE的累积概率。结果 MACE组三支病变发生率、入院时GRACE评分明显高于非MACE组,差异有统计学意义（P<0.05）;与非MACE组比较,MACE组LVEDD、空腹血糖、BNP、CRP、血糖SD和MAGE明显升高,LVEF降低,差异有统计学意义（均P<0.05）。Logistic多因素回归分析显示,三支病变、GRACE评分、BNP、CRP、血糖SD、MAGE均是ACS患者30 d发生MACE的独立危险因素（P均<0.05）。血糖SD预测MACE的曲线下面积（AUC）为0.883（95CI: 0.836~0.920, P<0.000 1）,最佳临界值为2.07 mmol/L,敏感性为82.1%,特异性为79.5%;高于血糖波动界值的ACS患者30 d内发生MACE累积概率明显增加（P<0.05）。结论血糖波动与ACS患者主要心血管不良事件风险密切相关,可作为早期评估患者不良预后的指标。

关键词: 急性冠脉综合征, 血糖波动, 主要心血管不良事件, 预后

Abstract: Objective To explore the predictive value of glycemic variability on the recent major cardiovascular adverse events in acute coronary syndrom patients. Methods From July 2016 to March 2018, a total of two hundred and forty-seven ACS patients in hospital were included. According to the 30-day follow-up whether occuring MACE, patients were classsfied into MACE group （n=28） and non-MACE group （n=219）, the general clinical data, biochemistry and ultrasonic and glycemic variability indexes were compared between two groups, the independent risk factors of MACE during 30-day follow-up of ACS patients were analyzed by using Logistic regression analysis. The predictive value of glycemic variability on MACE was assessed by using ROC curve. Meanwhile, the survival analysis were implemented by using Kaplan-Meier. Results The triple-vessel disease, GRACE scores on admission in the MACE group were significantly higher than in the non-MACE group （P<0.05）. Compared to the non-MACE group, the levels of LVEDD, fasting blood glucose, BNP, CRP, blood glucose standard deviation （BGSD）, mean amplitude of glycemic excursion （MAGE） were increased and LVEF were decreased in the MACE group, the differences between the two groups were statistically significant （all P<0.05）. Logistic regression analysis showed that triple-vessel disease, GRACE scores, BNP, CRP, BGSD, MAGE were independent risk factors for MACE in ACS patients during 30-day follow-up （all P<0.05）. The ROC curve analysis showed that BGSD predicted MACE with AUC was 0.883 （95CI: 0.836~0.920, P<0.000 1）, the cut-off value were 2.07 mmol/L, which yield sensitivity and specificity were 82.1% and 79.5%, respectively. The cumulative risk of MACE during 30-day follow-up increased markedly who over the cut-off value of glycemic variability （P<0.05）. Conclusion There is closely correlation between glycemic variability and recent major cardiovascular adverse events in acute coronary syndrom patients, its can be used as a factor for the poor prognosis of patients.

Key words: Acute coronary syndrom, Glycemic variability, Major cardiovascular adverse events, Prognosis

中图分类号:

R541.4

饶楚炳. 血糖波动对急性冠脉综合征患者近期主要心血管不良事件的预测价值[J]. 临床输血与检验, 2020, 22(2): 206-210.

RAO Chu-bing. A Predictive Value of Blood Glycemic Variability on The Recent Major Cardiovascular Adverse Events in Acute Coronary Syndrom Patients[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 206-210.

参考文献

1 Lee K, Yoo SY, Suh J,et al.Efficacy of cilostazol on inhibition of platelet aggregation, inflammation and myonecrosis in acute coronary syndrome patients undergoing percutaneous coronary intervention: The ACCEL-LOADING-ACS （ACCELerated Inhibition of platelet aggregation, inflammation and myonecrosis by adjunctive cilostazol loading in patients with acute coronary syndrome） study[J]. Int J Cardiol,2015,190（2）：370-375.
2 Ellis C，Hammett C，Ranasinghe I，et al.Comparison of the management and in-hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit[J]. Intern Med J，2015，45（5）：497-509.
3 Panduranga P，Sulaiman KJ，Al-Zakwani I, et al.Acute coronary syndrome in indian subcontinent patients residing in the middle east: results from gulf registry of acute coronary events II[J]. Angiology，2015，66（9）：818-825.
4 Gohbara M, Iwahashi N, Kataoka S, et al.Glycemic variability determined by continuous glucose nonitoring mystem predicts left ventricular remodeling in patients with a first ST-segment elevation myocardial Infarction[J]. Circ J，2015，79（5）：1092-1099.
5 Tokue M, Iijima R, Imamura T，et al.Impact of glycemic variability in patients with ST-elevated myocardial infarction[J]. Int J Cardiol，2015，187（1）：660-662.
6 Natsuaki M, Node K. Glycemic variability and cardiac remodeling in patients with acute myocardial infarction[J]. Circ J，2015，79（5）：972-973.
7 Nallamothu BK, Tommaso CL, Anderson HV,et al.ACC/AHA/SCAI/AMA-Conbened PCPI/NCQA 2013 Performance Measures for adults undergoing percutaneous coronary intervention：a report of the american college of cardiology/American heart association task force on performance measures, the society for cardiovascular angiography and interventions, the American medical association–convened physician consortium for performance improvement, and the national committee for quality assurance[J]. J Am Coll Cardiol，2014，63（7）：722-745.
8 Granger CB，Goldberg RJ，Dabbous O，et al.Predictors of hospital mortality in the global registry of acute coronary events[J]. Arch Intern Med，2003，163（19）：2345-2353.
9 González-Pacheco H, Márquez MF, Arias-Mendoza A, et al.Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation[J]. J Cardiol，2015，66（2）：148-154.
10 Ariza-Solé A, Formiga F, Salazar-Mendiguchía J, et al.Impact of anaemia on mortality and its causes in elderly patients with acute coronary syndromes[J]. Heart Lung Circ，2015，24（6）：557-565.
11 赖一炜,汤辉.改良GRACE评分对急性冠脉综合征患者危险评估局限性的研究进展[J].心脏杂志，2018，30（1）：99-102.
12 Al Jumaily T，Rose'Meyer RB，Sweeny A，et al.Cardiac damage associated with stress hyperglycaemia and acute coronary syndrome changes according to level of presenting blood glucose[J]. Int J Cardiol，2015，196（1）：16-21.
13 Vazquez-Benitez G，Desai JR，Xu S，et al.Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis[J]. Diabetes Care，2015，38（5）：905-912.
14 Mita T, Otsuka A, Azuma K, et al.Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice[J]. Biochem Biophys Res Commun，2007，358（3）：679-685.
15 Kasuya N, Ohta S, Takanami Y，et al.Effect of low glycemic index food and postprandial exercise on blood glucose level, oxidative stress and antioxidant capacity[J]. Exp Ther Med，2015，9（4）：1201-1204.
16 黄宗银.老年重症心力衰竭早期血小板和淋巴细胞比值与近期主要不良心脑血管事件的相关性分析[J].中国急救医学，2018，38（1）：31-36.
17 Kurl S, Zaccardi F，Onaemo VN，et al.Association between HOMA-IR, fasting insulin and fasting glucose with coronary heart disease mortality in nondiabetic men: a 20-year observational study[J]. Acta Diabetol，2015，52（1）：183-186.
18 穆东亮，敖虎山.非体外循环冠状动脉旁路移植术患者术中血糖波动水平与短期预后的关系[J].中华麻醉学杂志，2011，31（2）：141-143.
19 Xia J，Xu J，Li B，et al.Association between glycemic variability and major adverse cardiovascular and cerebrovascular events （MACCE） in patients with acute coronary syndrome during 30-day follow-up[J]. Clin Chim Acta，2017，466（1）：162-166.
20 Teraguchi I，Imanishi T，Ozaki Y，et al.Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction.[J]. Circ J，2014，78（1）：170-179.

[1]	李晓洁, 慈雪萍, 张俊. 血清CEA、CA125联合CA199对晚期肝内胆管细胞癌患者预后的预测作用[J]. 临床输血与检验, 2020, 22(4): 434-439.
[2]	马洁, 孙明, 钱广兵. 同型半胱氨酸对急性心力衰竭患者预后的相关性分析[J]. 临床输血与检验, 2020, 22(4): 440-443.
[3]	王海妮, 陈安青. 血清IFN-γ、IL-2、EGF预测鼻咽癌患者放疗敏感性和预后的相关性分析[J]. 临床输血与检验, 2020, 22(3): 300-304.
[4]	金梅, 马丹冬. 血清丙酸对感染性休克早期诊断及预后的评估价值[J]. 临床输血与检验, 2020, 22(1): 58-63.
[5]	魏世刚, 曾光群, 彭倩, 陈艳. 有丝分裂原活化蛋白激酶对HER-2阳性乳腺癌化疗疗效考核价值[J]. 临床输血与检验, 2020, 22(1): 77-81.
[6]	石琼梅, 惠朝晖, 张永顶, 龙国海. 血清降钙素原联合血小板平均体积检测对急性胰腺炎的病情预测价值[J]. 临床输血与检验, 2020, 22(1): 86-88.
[7]	常人亮, 王蓓, 胡良俊, 万玲玲, 李明. 外周血淋巴/中性粒细胞比值及淋巴/单核细胞比值对鼻咽癌患者预后的评估^*[J]. 临床输血与检验, 2019, 21(6): 630-632.
[8]	王云洁, 赵绍杰. MicroRNA-31表达与老年女性卵巢癌患者应用紫杉醇联合顺铂化疗的疗效及预后关系的研究*[J]. 临床输血与检验, 2019, 21(3): 236-238.
[9]	罗立, 冯锦红, 孔刘莎, 王迪生. β-catenin和cadherin蛋白联合血尿酸检测对DN预后的评估[J]. 临床输血与检验, 2019, 21(2): 180-183.
[10]	张锐东,张志发,李军. 输血相关急性肺损伤的危险因素及预后分析[J]. 临床输血与检验, 2018, 20(4): 368-370.
[11]	王恋, 颜浩, 王玉珠, 何晨韵, 吴驰, 徐婷. IL-32在不同分期哮喘患者血清中的表达比较^*[J]. 临床输血与检验, 2018, 20(2): 160-163.
[12]	吴新萍. GLS1在胃癌患者癌组织的表达水平及其与临床预后的关系[J]. 临床输血与检验, 2018, 20(2): 168-173.
[13]	徐磊霞, 许琴, 曹娟. RBP联合尿液蛋白检测对慢性肾小球肾炎预后的评估^*[J]. 临床输血与检验, 2018, 20(1): 54-57.
[14]	李硕, 梁晴, 翟秀娟. 急性冠脉综合征患者心肌损伤标志物cTnI、CK-MB、Fib表达与意义^*[J]. 临床输血与检验, 2018, 20(1): 73-75.
[15]	郭飞波, 杨勇. 胃癌组织低氧诱导因子1α及受控基因与临床病理特点的关系[J]. 临床输血与检验, 2017, 19(3): 265-271.

血糖波动对急性冠脉综合征患者近期主要心血管不良事件的预测价值

A Predictive Value of Blood Glycemic Variability on The Recent Major Cardiovascular Adverse Events in Acute Coronary Syndrom Patients

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们